Ultherapy Korea vs US — Honest Cost-Benefit Decision Framework

Y'all, let me do the thing nobody else does: tell you when the Korea Ultherapy trip does not pencil out. Most travel-medical content on the internet treats this question as foregone conclusion (Korea always cheaper, always go). The honest answer is more interesting and depends on your US origin city, your home-state clinic price, your shot tier, and how you value the seven-to-fourteen days of trip time. This page is the cost-benefit framework I run for every patient who emails me from Texas, Florida, California, the Carolinas, or the Northeast asking whether to book the flight. Three numbers anchor the math: the all-in Korea trip cost (flight from your US origin plus hotel plus treatment), the US clinic price for the same shot tier and device generation, and the time-cost of the trip days. The break-even line moves with all three, but the rough rule that holds across most patients is this — if your US clinic quotes USD 2,800 or higher for full-face Ultherapy PRIME at 600 shots, the Korea trip pencils out from any major US origin city. If your US quote is USD 2,200-2,800, the trip pencils out from west-coast and central-US origins but not always from the East Coast. If your US quote is below USD 2,200, the trip rarely pencils out unless you genuinely wanted a Korea vacation anyway. Below is the math, the assumptions, and the four cases where flying does not make financial sense.

The three-number framework

The Korea-versus-US Ultherapy decision is a three-number problem. Number one: all-in Korea trip cost equals round-trip flight from your US origin to ICN plus four to five nights of hotel plus the Korean treatment cost (in USD-equivalent at the spot rate). Number two: US clinic price for full-face Ultherapy PRIME at the same shot tier (typically 600 shots), all-in including any consult fee, after-care visit, and tax. Number three: the time-and-opportunity cost of the trip days, which is positive (you wanted a Korea vacation, the trip days are recreational gain) for some patients and negative (PTO is precious, time away from family is real) for others. Subtract number two from number one and you have the headline savings or premium of the Korea trip. Add or subtract number three's time value to get the true net. The headline savings band across the cases I have run for friends and readers is roughly USD 800 to USD 2,200 in favor of Korea, before time-cost adjustment. After time-cost adjustment, the band narrows to roughly USD 400 to USD 1,800. The net-positive zone is real and meaningful, but it is not the universe-wide certainty that travel-medical marketing implies.

• Number 1: All-in Korea trip cost (flight + 4-5 hotel nights + treatment in USD)
• Number 2: US clinic price for full-face PRIME 600 shots all-in
• Number 3: Time-and-opportunity cost of 5-14 trip days (positive or negative)
• Headline savings: Number 2 minus Number 1 (typically USD 800-2,200)
• Net savings: Headline minus or plus Number 3 (typically USD 400-1,800)

Number 1 — All-in Korea trip cost by US origin

Round-trip economy flight pricing from US origins to ICN in 2026 shoulder season (April-May, October-November), based on a 90-day-out booking window. DFW-ICN runs USD 1,200-1,600. IAD-ICN runs USD 1,300-1,700. JFK-ICN runs USD 1,300-1,800. LAX-ICN runs USD 1,000-1,400 (the cheapest US origin because of the Pacific routing). SFO-ICN runs USD 1,000-1,400. SEA-ICN runs USD 950-1,350 (often the cheapest US origin overall on Korean Air or Asiana). ORD-ICN runs USD 1,200-1,650. ATL-ICN runs USD 1,300-1,750 (typically routed through DFW or LAX). Hotel cost in Gangnam runs USD 110-220 per night for a clean 4-star international chain (Lotte, Marriott, Westin), USD 75-120 for a clean 3-star Korean business hotel. Four to five hotel nights total USD 400-1,100. Treatment cost from the cost map page: full-face PRIME 600 shots in Cheongdam-Gangnam runs USD 1,328-1,771 at the 2026-05-10 BOK reference rate; in Myeongdong USD 1,107-1,402; in Hongdae USD 1,033-1,292; in Haeundae Busan USD 1,107-1,476; in Daegu USD 886-1,107. Add USD 60-120 for ground transport in country (AREX, taxis), USD 200-350 for food across five days, USD 100-200 for incidentals. All-in Korea trip cost band from a representative US origin: from LAX/SFO, USD 2,700-3,800; from DFW/ORD, USD 2,900-4,100; from JFK/IAD, USD 3,000-4,300; from SEA, USD 2,650-3,750.

Number 2 — US clinic price by metro

US dermatology clinic pricing for full-face Ultherapy PRIME at the 600-shot tier varies widely by metro, with major-coast metros priced 30-50 percent above secondary metros. The bands I compiled from published US clinic price lists and patient-reported quotes during the May 2026 refresh: Manhattan and Beverly Hills run USD 3,500-4,800; San Francisco, Boston, Washington DC run USD 3,200-4,200; Dallas, Houston, Atlanta, Denver, Miami run USD 2,800-3,800; Austin, Nashville, Charlotte, Phoenix run USD 2,400-3,400; secondary metros (Indianapolis, Kansas City, Salt Lake City, Pittsburgh) run USD 2,200-3,000. These bands assume Ultherapy PRIME (the upgraded device generation) and a single-session 600-shot full-face protocol; legacy Ulthera or compressed shot counts will price below the band. Some US dermatology practices in major metros do not price-list publicly and quote at consultation; these tend to land at the upper end of the band for the metro. The PRIME-versus-Ulthera differential matters a great deal — a US quote that comes in below USD 2,000 should be cross-checked for device generation before any cost-benefit comparison.

Number 3 — Time-and-opportunity cost

This is the most patient-specific number on the framework and the one most cost calculators ignore. Five to fourteen trip days carry an opportunity cost that varies wildly by patient circumstance. For the patient who genuinely wanted a Korea vacation, the trip days are recreational gain and Number 3 is negative — meaning it reduces the effective trip cost. For the patient with a high-pay W-2 job who burns paid vacation on the trip, Number 3 is roughly the daily PTO value times the trip days, which can run USD 1,000-3,000 for a five-day trip and USD 2,500-6,000 for a 10-day trip. For the patient with school-age kids whose at-home logistics break without them, Number 3 includes any childcare or coverage costs (USD 200-500 per day is typical for in-home help in major US metros). For the entrepreneur or self-employed patient, Number 3 is the foregone billable time, which can be substantial. The honest practice is to write your own Number 3 in your own circumstances and add or subtract it from the headline savings. Patients who do not honestly account for Number 3 are the ones who come back from Korea with positive procedure outcomes and complicated feelings about the trip.

The four cases where the trip does not pencil out

Case one: your US clinic price is below USD 2,200 for the same shot tier and device generation. The headline savings disappears at this threshold for most US origins because flight plus hotel plus treatment in Korea hits USD 2,650-3,000 minimum from the cheapest US origins. Case two: your time-and-opportunity cost (Number 3) is unusually high. A self-employed consultant billing USD 2,000+ per day cannot easily absorb a 7-day trip on the math, even if the headline procedure savings is USD 1,500. Case three: you cannot take seven consecutive PTO days. A compressed five-day Korea Ultherapy trip is the absolute minimum (treatment day three, fly home day five), and even that is tight; if your work schedule forces a four-day-or-less attempt, do not try it. Case four: this is a first-time international medical travel experience and your stress tolerance is moderate. The procedure-plus-Korea-logistics learning curve is real on trip one; some patients are better served paying the US premium for trip one, then doing trip two as Korea-comfort returning patient. None of these four cases is wrong; they are just the cases where the math, the schedule, or the personal-fit answer shifts. The other 70 percent of patients who run the framework end up net-positive on Korea, often by USD 500-1,500 after honest time-cost adjustment.

What the math does not capture

Two things the headline cost-benefit math cannot capture. One: the device-generation premium. Korea has the deepest authorized-provider footprint for Ultherapy PRIME, the upgraded Merz device generation; the US footprint is still mixed between PRIME and the legacy Ulthera unit, especially in secondary metros. If your US quote is for legacy Ulthera and your Korea quote is for PRIME, you are not comparing the same procedure, and the Korea side gains a quality-comparable advantage that does not show up in the won figure. Two: the multi-treatment combination value. Most Korea trips that pencil out do so partly because the patient combines Ultherapy with one skin booster session, one Thermage FLX consult, or one Sofwave evaluation in the same trip — the all-in cost of two or three combination treatments in Korea often runs below the cost of just Ultherapy at a US Manhattan or Beverly Hills clinic. The combination math is patient-specific and depends on what you would have done in the US over the next 12 months anyway. Run it honestly. Both of these factors typically push the verdict toward Korea-pencils-out, but they are not certainties.

“Run all three numbers, including the time cost. The Korea Ultherapy trip pencils out for most US patients, but not all of them, and the seven-to-fourteen days of trip time matters more than most cost calculators admit. Honest math beats marketing math every time.”

Sarah Mitchell, Korea Ultherapy decision-framework field notes

Frequently asked questions

What's the rough break-even US clinic price below which the Korea trip does not pencil out?

USD 2,200 for full-face PRIME 600 shots all-in is the rough break-even floor. Below that, the all-in Korea trip cost from the cheapest US origins (LAX, SEA) starts to absorb the headline savings, and once you add honest time-cost adjustment, the trip rarely nets positive. Above USD 2,800 the trip pencils out from any major US origin; between USD 2,200-2,800 it depends on origin and Number 3.

Does the math change if I want to combine Ultherapy with skin booster or Thermage in the same trip?

Yes, and almost always in favor of Korea. A Korea trip with Ultherapy plus one skin booster session typically adds USD 350-700 versus a single-treatment Korea trip; a US patient who would have done a separate skin booster in the US over the next 12 months would have spent USD 600-1,200 on that booster stateside. The combination configuration tends to widen the Korea net-positive band by USD 300-700 per added treatment.

How much does the exchange rate matter to the decision?

More than most patients realize. The cost map and break-even tables on this site assume USD/KRW 1,355 (Bank of Korea reference rate 2026-05-10). A 5 percent move in either direction shifts the headline savings by USD 70-100 on a typical Korea trip. If USD/KRW moves below 1,290 before your travel date (won strengthens against dollar), recompute before you book; the headline savings can compress meaningfully.

What if I'm already planning a Korea vacation anyway?

Then Number 3 (time-and-opportunity cost) is materially negative — it is recreational gain, not opportunity cost — and the procedure economics get more attractive. The flight cost is a sunk vacation cost, the hotel is partly attributable to the vacation, and only the treatment itself is the incremental Ultherapy cost. In that scenario, USD 1,200-1,800 for full-face PRIME at a Cheongdam clinic is a clear win over any US clinic price above USD 2,000.

Is the cost differential because Korean clinics are cheaper, or because I'm getting less procedure?

Cheaper, not less. The Ultherapy device, the FDA and MFDS-cleared protocol, the shot count, the depth targeting — all the same. What differs is the operating-cost stack: Korean dermatology clinic real-estate cost is lower than Manhattan or Beverly Hills, the labor cost is lower, the malpractice insurance environment is different, and the volume of procedures per clinic is higher (which spreads fixed costs across more patients). The procedure is the procedure; the price reflects the underlying cost structure.

Should I factor in travel insurance and currency conversion fees?

Yes, lightly. Travel medical insurance for the trip runs USD 50-150 per traveler depending on duration and coverage; currency-conversion fees on a US travel card typically run 1-3 percent on the Korean treatment payment, which is USD 12-50 on a USD 1,200-1,800 procedure cost. Together these run USD 60-200 — meaningful at the margin but not decisive on the headline math.

What about emergencies — what if something goes wrong post-procedure after I fly home?

Genuinely unusual for Ultherapy specifically, which has a low post-procedure complication rate, but worth planning for. The right move is to identify a US dermatologist before you fly to Korea who is willing to see you for any post-procedure follow-up, and to get the Korean physician's written aftercare instructions in English to share with the US doctor. Most US dermatologists will see a returning Ultherapy patient for a follow-up consultation; budget USD 200-400 for that visit if you need it.

Are returning patients getting better deals?

Sometimes, modestly. Some Korean clinics offer returning-patient discounts (5-10 percent) or package configurations (3-treatment-over-18-months bundle) that price favorably for committed repeat travelers. The first-trip pricing is typically the published list price; the trip-two and trip-three configurations have more flexibility. Ask in writing on WhatsApp before booking — Korean clinics tend to honor written quotes.